earnings
TG
NASDAQ · TGTX
TG Therapeutics, Inc.
Healthcare · Biotechnology
$53.04
Up+$2.81 (+5.30%)
Updated Sep 16, 2026, 10:18 PM
SID Score
5.8/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 5.08B
- P/E ratio
- 77.67
- Dividend yield
- 0.00%
- 52-week range
- $26.76 – $59.30
- Volume
- 1.76M
- Avg. volume
- 1.87M
Price performance
TGTX price history
1M range · 20 trading sessions · Daily adjusted prices
TGTX closed at $53.04 after 20 trading sessions, up 5.53% for the selected period.
- Last close
- $53.04
- Period change
- +5.53%
- Period low
- $50.26
- Period high
- $56.90
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $53.59 | $54.4124 | $52.5001 | $53.04 | 1.76M |
| Sep 14, 2026 | $53.97 | $54.20 | $53.19 | $54.00 | 1.36M |
| Sep 11, 2026 | $55.71 | $56.26 | $53.47 | $53.89 | 1.37M |
| Sep 10, 2026 | $54.36 | $55.41 | $54.01 | $55.39 | 1.37M |
| Sep 9, 2026 | $55.55 | $57.14 | $54.24 | $54.65 | 1.41M |
| Sep 8, 2026 | $55.34 | $55.925 | $54.09 | $55.74 | 1.09M |
| Sep 4, 2026 | $56.30 | $56.70 | $55.56 | $55.985 | 992.97K |
| Sep 3, 2026 | $57.40 | $58.47 | $56.19 | $56.71 | 1.57M |
| Sep 2, 2026 | $56.18 | $57.87 | $54.70 | $56.90 | 2.36M |
| Sep 1, 2026 | $53.00 | $56.27 | $52.11 | $56.09 | 3.2M |
| Aug 31, 2026 | $53.58 | $54.36 | $52.67 | $54.30 | 1.62M |
| Aug 28, 2026 | $55.53 | $55.53 | $53.83 | $53.93 | 1.03M |
| Aug 27, 2026 | $55.00 | $55.97 | $54.15 | $55.72 | 1.22M |
| Aug 26, 2026 | $55.50 | $56.04 | $54.53 | $55.03 | 963.31K |
| Aug 25, 2026 | $56.66 | $57.90 | $54.68 | $55.42 | 1.99M |
| Aug 24, 2026 | $53.19 | $56.49 | $52.00 | $56.01 | 2.85M |
| Aug 21, 2026 | $51.10 | $56.87 | $49.97 | $54.27 | 5.56M |
| Aug 20, 2026 | $51.65 | $53.18 | $50.52 | $50.56 | 2.44M |
| Aug 19, 2026 | $51.62 | $52.335 | $50.71 | $51.69 | 1.29M |
| Aug 18, 2026 | $49.28 | $50.29 | $48.98 | $50.26 | 1.2M |
Latest TGTX news
The latest Smart Investors Daily articles mentioning TGTX.
Stock researchCompany · Financials
Loading stock research…